Oncology
Opinion: Covid-19 Pandemic—An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology?
3 Jul, 2020 | 08:26h | UTCCovid-19 Pandemic—An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology? – JAMA Oncology (free for a limited period)
Randomized Trial: Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer
29 Jun, 2020 | 09:00h | UTCCommentary: Daily UDCA Reduced Gallstone Formation in Gastric Cancer Patients Following Gastrectomy – Physician’s Weekly
Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
24 Jun, 2020 | 03:16h | UTCTreatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline – Journal of Clinical Oncology
What Oncologists Should Know About Treating Sexual and Gender Minority Patients with Cancer
19 Jun, 2020 | 09:30h | UTC
Randomized Trial: Atezolizumab, Vemurafenib, and Cobimetinib for Advanced BRAFV600 Mutation-positive Melanoma
16 Jun, 2020 | 07:48h | UTC
Analysis: Shifting, Overlapping and Expanding Use of “Precision Oncology” Terminology
16 Jun, 2020 | 07:46h | UTC
Randomized Trial: Cancer Prevention with Aspirin in Hereditary Colorectal Cancer (Lynch syndrome)
12 Jun, 2020 | 09:04h | UTCInvited Commentary: Aspirin for Lynch syndrome: a legacy of prevention – The Lancet
Global Trends in Thyroid Cancer Incidence and the Impact of Overdiagnosis
12 Jun, 2020 | 08:59h | UTCGlobal trends in thyroid cancer incidence and the impact of overdiagnosis – The Lancet Diabetes & Endocrinology (free for a limited period)
Commentaries: New IARC study on global expansion in overdiagnosis of thyroid cancer – International Agency for Research on Cancer AND Thyroid cancer overdiagnosis reaches beyond affluent regions – MDedge
ASTRO Guideline: Radiation Therapy for Cervical Cancer
11 Jun, 2020 | 09:20h | UTCCommentary: ASTRO’s new guideline provides recommendations for radiation therapy to treat cervical cancer – News Medical
American Cancer Society Guideline for Diet and Physical Activity for Cancer Prevention
10 Jun, 2020 | 04:46h | UTCNews Release: American Cancer Society Updates Diet & Physical Activity Guideline for Cancer Prevention
Systematic Review: Radical Prostatectomy vs. Deferred Treatment for Localized Prostate Cancer
5 Jun, 2020 | 04:34h | UTCRadical prostatectomy versus deferred treatment for localised prostate cancer – Cochrane Library
[Abstract Only] Randomized Trial: 39·0°C vs. 38·5°C Ear Temperature as Fever Limit in Children with Neutropenia Undergoing Chemotherapy for Cancer
3 Jun, 2020 | 03:34h | UTC39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial – The Lancet Child & Adolescent Health (link to abstract – $ for full-text)
ASCO Special Report: A Guide to Cancer Care Delivery During the COVID-19 Pandemic
2 Jun, 2020 | 04:57h | UTCNews Release: Special Report Provides Guidance to Oncology Practices on Resuming Cancer Care During COVID-19 Pandemic
Related: ESMO Guidelines: Cancer Patient Management During the Covid-19 Pandemic
Cohort Studies: Clinical Impact of COVID-19 on Patients with Cancer
1 Jun, 2020 | 04:00h | UTCStudy 1: Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study – The Lancet
Commentaries: Studies highlight COVID-19 impact on cancer patients – CIDRAP AND Cancer, coronavirus are a dangerous mix, new studies find – MedicalXpress AND Cancer, coronavirus are a dangerous mix, new studies find – Associated Press AND Cancer and COVID-19: what do we really know? – The Lancet
[Abstract Only] #ASCO20 – Randomized Trial: Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
1 Jun, 2020 | 03:33h | UTC
[Abstract Only] #ASCO20 – Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
1 Jun, 2020 | 03:32h | UTC
Meta-Analysis: Direct Oral Anticoagulants vs. Low‐molecular‐weight Heparin for the Treatment of Cancer‐associated Thrombosis
29 May, 2020 | 03:03h | UTC“In patients with cancer‐associated VTE, DOACs are more effective in preventing recurrent VTE compared to LMWH. However, risk of bleeding is increased with DOACs, especially in patients with GI cancer.”
Meta-Analysis: Negative Predictive Value of MRI in the Detection of Clinically Significant Prostate Cancer
28 May, 2020 | 09:35h | UTC
Impact of COVID-19 on Oncology Clinical Trials
26 May, 2020 | 09:40h | UTCImpact of COVID-19 on oncology clinical trials – Nature Reviews Drug Discovery
Commentary: More Than 200 International Cancer Trials Suspended Due to COVID-19 – Medscape (free registration required)
Summary of International Recommendations in 23 Languages for Patients with Cancer During the COVID-19 Pandemic
15 May, 2020 | 03:29h | UTCRelated: ESMO Guidelines: Cancer Patient Management During the Covid-19 Pandemic (guidelines on the subject)
[Abstract Only] Randomized Trial: Improved Overall Survival with Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
15 May, 2020 | 03:23h | UTCSee also: Visual Abstract
[Abstract Only] Cost–benefit Analysis of Cancer Drugs in the USA and Europe
14 May, 2020 | 02:25h | UTCPrices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis – The Lancet Oncology (link to abstract – $ for full-text)
Commentaries: High cost of cancer drugs not always justified – University of Zurich AND High Cost of Cancer Drugs Does Not Reflect Clinical Benefit – Medscape
NCCN Guideline: Hematopoietic Cell Transplantation
10 May, 2020 | 23:53h | UTC
ESMO Guidelines: Cancer Patient Management During the Covid-19 Pandemic
5 May, 2020 | 04:41h | UTCCancer Patient Management During the Covid-19 Pandemic – European Society of Medical Oncology
Related: NCCN Guidance: How to Keep our Oncology Patients and Healthcare Workers Safe AND ASCO Recommendations for the Oncology Community During the COVID19 Pandemic AND COVID-19 rapid guideline: delivery of systemic anticancer treatments – NICE AND COVID-19 rapid guideline: delivery of radiotherapy – NICE AND Caring for patients with cancer in the COVID-19 era – Nature Medicine
EULAR Recommendations: Diagnosis and Management of Rheumatic Adverse Events due to Cancer Immunotherapy
5 May, 2020 | 05:18h | UTCRelated: Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy – Rheumatology AND Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature – Current Drug Safety AND Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist – The Journal of Rheumatology AND NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities (guidelines and reviews on the subject)